SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/05/20 AgroFresh Solutions, Inc. 10-Q 9/30/20 90:8.8M |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 919K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 28K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 28K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 26K 11: R1 Cover Page HTML 76K 12: R2 Condensed Consolidated Balance Sheets HTML 128K 13: R3 Condensed Consolidated Balance Sheets HTML 45K (Parenthetical) 14: R4 Condensed Consolidated Statements of Operations HTML 120K 15: R5 Condensed Consolidated Statements of Comprehensive HTML 45K Loss 16: R6 Condensed Consolidated Statements of Comprehensive HTML 28K Loss (Parenthetical) 17: R7 Condensed Consolidated Statement of Stockholders' HTML 78K Equity 18: R8 Condensed Consolidated Statement of Cash Flows HTML 124K 19: R9 Description of Business HTML 30K 20: R10 Basis of Presentation and Summary of Significant HTML 143K Accounting Policies 21: R11 Business Combinations and Asset Acquisition HTML 30K 22: R12 Related Party Transactions HTML 29K 23: R13 Inventories HTML 32K 24: R14 Other Current Assets HTML 31K 25: R15 Property and Equipment HTML 36K 26: R16 Goodwill and Intangible Assets HTML 69K 27: R17 Other Assets HTML 31K 28: R18 Accrued and Other Current Liabilities HTML 37K 29: R19 Debt HTML 52K 30: R20 Leases HTML 54K 31: R21 Other Noncurrent Liabilities HTML 30K 32: R22 Severance HTML 26K 33: R23 Series B Convertible Preferred Stock and HTML 55K Stockholders' Equity 34: R24 Stock-based Compensation HTML 26K 35: R25 Earnings Per Share HTML 47K 36: R26 Income Taxes HTML 33K 37: R27 Segment Information HTML 46K 38: R28 Commitments and Contingencies HTML 28K 39: R29 Fair Value Measurements HTML 61K 40: R30 Basis of Presentation and Summary of Significant HTML 146K Accounting Policies (Policy) 41: R31 Basis of Presentation and Summary of Significant HTML 132K Accounting Policies (Tables) 42: R32 Inventories (Tables) HTML 33K 43: R33 Other Current Assets (Tables) HTML 31K 44: R34 Property and Equipment (Tables) HTML 35K 45: R35 Goodwill and Intangible Assets (Tables) HTML 72K 46: R36 Other Assets (Tables) HTML 31K 47: R37 Accrued and Other Current Liabilities (Tables) HTML 37K 48: R38 Debt (Tables) HTML 42K 49: R39 Leases (Tables) HTML 55K 50: R40 Other Noncurrent Liabilities (Tables) HTML 30K 51: R41 Series B Convertible Preferred Stock and HTML 45K Stockholders' Equity (Tables) 52: R42 Earnings Per Share (Tables) HTML 46K 53: R43 Segment Information (Tables) HTML 41K 54: R44 Fair Value Measurements (Tables) HTML 62K 55: R45 Description of Business (Details) HTML 26K 56: R46 Basis of Presentation and Summary of Significant HTML 37K Accounting Policies - Narrative (Details) 57: R47 Basis of Presentation and Summary of Significant HTML 76K Accounting Policies - Summary of Disaggregation of Revenue (Details) 58: R48 Basis of Presentation and Summary of Significant HTML 43K Accounting Policies - Summary of Contract Assets and Liabilities (Details) 59: R49 Business Combinations and Asset Acquisition HTML 71K (Details) 60: R50 Related Party Transactions (Details) HTML 45K 61: R51 Inventories (Details) HTML 35K 62: R52 Other Current Assets (Details) HTML 33K 63: R53 Property and Equipment (Details) HTML 57K 64: R54 Goodwill and Intangible Assets - Schedule of HTML 28K Goodwill (Details) 65: R55 Goodwill and Intangible Assets - Schedule of HTML 78K Intangible Assets (Details) 66: R56 Goodwill and Intangible Assets - Future HTML 42K Amortization (Details) 67: R57 Other Assets (Details) HTML 31K 68: R58 Accrued and Other Current Liabilities (Details) HTML 49K 69: R59 Debt - Net of Unamortized Discounts and Deferred HTML 37K Financing Fees (Details) 70: R60 Debt - Narrative (Details) HTML 138K 71: R61 Debt - Principal Repayments (Details) HTML 37K 72: R62 Leases - Additional Information on Operating HTML 40K Leases (Details) 73: R63 Leases - Maturities of Lease Liabilities: Current HTML 40K Period (Details) 74: R64 Leases - Maturities of Lease Liabilities: Prior HTML 40K Period (Details) 75: R65 Other Noncurrent Liabilities (Details) HTML 30K 76: R66 Severance (Details) HTML 29K 77: R67 Series B Convertible Preferred Stock and HTML 134K Stockholders' Equity (Details) 78: R68 Series B Convertible Preferred Stock and HTML 53K Stockholders' Equity - Temporary Equity (Details) 79: R69 Stock-based Compensation - Narrative (Details) HTML 39K 80: R70 Earnings Per Share - Schedule of Weighted Average HTML 31K Common Shares Outstanding (Details) 81: R71 Earnings Per Share (Details) HTML 38K 82: R72 Income Taxes (Details) HTML 27K 83: R73 Segment Information (Details) HTML 43K 84: R74 Commitment and Contingencies (Details) HTML 29K 85: R75 Fair Value Measurements - Financial Instruments HTML 66K Measured on a Recurring Basis (Details) 86: R76 Fair Value Measurements - Changes of Level 3 HTML 47K Financial Instruments (Details) 88: XML IDEA XML File -- Filing Summary XML 164K 10: XML XBRL Instance -- agfs-20200930_htm XML 2.51M 87: EXCEL IDEA Workbook of Financial Reports XLSX 107K 6: EX-101.CAL XBRL Calculations -- agfs-20200930_cal XML 277K 7: EX-101.DEF XBRL Definitions -- agfs-20200930_def XML 620K 8: EX-101.LAB XBRL Labels -- agfs-20200930_lab XML 1.75M 9: EX-101.PRE XBRL Presentations -- agfs-20200930_pre XML 1.00M 5: EX-101.SCH XBRL Schema -- agfs-20200930 XSD 174K 89: JSON XBRL Instance as JSON Data -- MetaLinks 434± 617K 90: ZIP XBRL Zipped Folder -- 0001592016-20-000110-xbrl Zip 317K
agfs-20200930 |
i Delaware | i 46-4007249 | ||||
(State or other jurisdiction of incorporation) | (IRS Employer Identification Number) |
Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||||||||||||
i Common Stock, par value $0.0001 per share | i AGFS | i The Nasdaq Stock Market LLC |
Large accelerated filer ☐ | Accelerated
filer ☐ | i Non-accelerated filer ☒ | Smaller reporting company i ☒ | Emerging
growth company i ☐ |
Page | |||||||||||
September 30, 2020 | December
31, 2019 | |||||||
ASSETS | ||||||||
Current Assets: | ||||||||
Cash and cash equivalents | $ | i 25,149 | $ | i 29,288 | ||||
Accounts
receivable, net of allowance for doubtful accounts of $ i 2,025 and $ i 2,232, respectively | i 69,580 | i 68,634 | ||||||
Inventories | i 24,444 | i 22,621 | ||||||
Other current assets | i 17,265 | i 11,802 | ||||||
Total Current Assets | i 136,438 | i 132,345 | ||||||
Property and equipment, net | i 13,275 | i 13,177 | ||||||
Goodwill | i 6,605 | i 6,323 | ||||||
Intangible assets, net | i 599,236 | i 631,369 | ||||||
Deferred income tax assets | i 10,502 | i 10,317 | ||||||
Other assets | i 11,449 | i 12,161 | ||||||
TOTAL ASSETS | $ | i 777,505 | $ | i 805,692 | ||||
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||
Current Liabilities: | ||||||||
Accounts payable | $ | i 13,784 | $ | i 15,105 | ||||
Current portion of long-term debt | i 3,316 | i 4,675 | ||||||
Income taxes payable | i 7,629 | i 5,648 | ||||||
Accrued expenses and other current liabilities | i 26,665 | i 24,350 | ||||||
Total Current Liabilities | i 51,394 | i 49,778 | ||||||
Long-term debt | i 264,850 | i 398,064 | ||||||
Other noncurrent liabilities | i 5,989 | i 7,246 | ||||||
Deferred income tax liabilities | i 35,577 | i 16,574 | ||||||
Total Liabilities | i 357,810 | i 471,662 | ||||||
Commitments and contingencies (see Note 20) | i | i | ||||||
Series B convertible preferred stock, par value $ i i 0.0001 / ;
i 150,000 and i 0 shares authorized, i 150,000
and i 0 shares designated and outstanding at September 30, 2020 and December 31, 2019, respectively | i 140,684 | i — | ||||||
Stockholders’ Equity: | ||||||||
Common stock, par value $ i i 0.0001 / ;
i i 400,000,000 / shares authorized, i 53,054,960
and i 51,839,527 shares issued and i 52,393,579 and i 51,178,146
outstanding at September 30, 2020 and December 31, 2019, respectively | i 5 | i 5 | ||||||
Preferred
stock, par value $ i i 0.0001 / ;
i i i i 1 / / /
share authorized and outstanding at September 30, 2020 and December 31, 2019, respectively | i — | i — | ||||||
Treasury
stock, par value $ i i 0.0001 / ; i i 661,381 /
shares at September 30, 2020 and December 31, 2019, respectively | ( i 3,885) | ( i 3,885) | ||||||
Additional paid-in capital | i 559,037 | i 561,006 | ||||||
Accumulated deficit | ( i 241,710) | ( i 199,621) | ||||||
Accumulated other comprehensive loss | ( i 41,164) | ( i 31,060) | ||||||
Total AgroFresh Stockholders’ Equity | i 272,283 | i 326,445 | ||||||
Non-controlling interest | i 6,728 | i 7,585 | ||||||
Total
Stockholders' Equity | i 279,011 | i 334,030 | ||||||
TOTAL LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY | $ | i 777,505 | $ | i 805,692 |
Three
Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine Months Ended September 30, 2019 | |||||||||||
Net sales | $ | i 52,770 | $ | i 48,972 | $ | i 105,775 | $ | i 109,095 | ||||||
Cost of sales (excluding amortization, shown separately below) | i 13,511 | i 13,892 | i 28,492 | i 31,516 | ||||||||||
Gross profit | i 39,259 | i 35,080 | i 77,283 | i 77,579 | ||||||||||
Research and development expenses | i 2,852 | i 2,566 | i 8,389 | i 9,720 | ||||||||||
Selling, general and administrative expenses | i 13,494 | i 14,998 | i 39,925 | i 47,044 | ||||||||||
Amortization of intangibles | i 10,973 | i 11,754 | i 32,866 | i 35,136 | ||||||||||
Impairment of long lived assets | i — | i — | i — | i 992 | ||||||||||
Change in fair value of contingent consideration | i — | ( i 229) | i — | i 128 | ||||||||||
Grant income | i — | i — | ( i 2,974) | i — | ||||||||||
Operating income (loss) | i 11,940 | i 5,991 | ( i 923) | ( i 15,441) | ||||||||||
Other income (expense) | i 96 | ( i 81) | i 1,596 | ( i 119) | ||||||||||
Debt modification and extinguishment expenses | ( i 5,028) | i — | ( i 5,028) | i — | ||||||||||
Gain (loss) on foreign currency exchange | i 1,390 | i 54 | i 2,466 | ( i 2,884) | ||||||||||
Interest expense, net | ( i 4,922) | ( i 8,606) | ( i 18,401) | ( i 26,021) | ||||||||||
Gain (loss) before income taxes | i 3,476 | ( i 2,642) | ( i 20,290) | ( i 44,465) | ||||||||||
Income taxes expense (benefit) | i 25,857 | ( i 5,653) | i 22,656 | ( i 12,530) | ||||||||||
Net (loss) income including non-controlling interests | ( i 22,381) | i 3,011 | ( i 42,946) | ( i 31,935) | ||||||||||
Less: Net loss attributable to non-controlling interests | ( i 494) | ( i 278) | ( i 857) | ( i 336) | ||||||||||
Net (loss) income attributable to AgroFresh Solutions, Inc | ( i 21,887) | i 3,289 | ( i 42,089) | ( i 31,599) | ||||||||||
Less: Dividends on convertible preferred stock | i 4,400 | i — | i 4,400 | i — | ||||||||||
(Loss) income attributable to AgroFresh Solutions, Inc. common stockholders | $ | ( i 26,287) | $ | i 3,289 | $ | ( i 46,489) | $ | ( i 31,599) | ||||||
Net (loss) income per share: | ||||||||||||||
Basic | $ | ( i 0.52) | $ | i 0.06 | $ | ( i 0.92) | $ | ( i 0.64) | ||||||
Diluted | $ | ( i 0.52) | $ | i 0.06 | $ | ( i 0.92) | $ | ( i 0.64) | ||||||
Weighted average shares outstanding: | ||||||||||||||
Basic | i 51,001,852 | i 50,227,590 | i 50,765,829 | i 50,138,835 | ||||||||||
Diluted | i 51,001,852 | i 50,288,304 | i 50,765,829 | i 50,138,835 |
Three
Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine Months Ended September 30, 2019 | |||||||||||
Net (loss) income | $ | ( i 22,381) | $ | i 3,011 | $ | ( i 42,946) | $ | ( i 31,935) | ||||||
Other comprehensive (loss) income: | ||||||||||||||
Unrealized gain (loss) on hedging activity, net of tax of $ i 61, $ i 24,
($ i 81) and $ i 24,
respectively | i 229 | i 83 | ( i 304) | i 83 | ||||||||||
Recognition
of gain on hedging activity reclassified to net loss, net of tax of ($ i 239), ($ i 78),
($ i 398) and ($ i 235),
respectively | ( i 857) | ( i 278) | ( i 1,411) | ( i 834) | ||||||||||
Foreign currency translation adjustments | i 296 | ( i 3,823) | ( i 8,389) | ( i 903) | ||||||||||
Comprehensive
loss, net of tax | $ | ( i 22,714) | $ | ( i 1,007) | $ | ( i 53,050) | $ | ( i 33,589) |
Preferred Stock | Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Non-Controlling Interest | Total Stockholders’ Equity | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Amount | ||||||||||||||||||||||||||||
Balances, December 31, 2019 | i 1 | $ | i — | i 51,839,527 | $ | i 5 | $ | ( i 3,885) | $ | i 561,006 | $ | ( i 199,621) | $ | ( i 31,060) | $ | i 7,585 | $ | i 334,030 | ||||||||||||||
Stock-based compensation | — | — | — | — | — | i 2,473 | — | — | — | i 2,473 | ||||||||||||||||||||||
Issuance of stock, net of forfeitures | — | — | i 1,178,663 | — | — | — | — | — | — | — | ||||||||||||||||||||||
Shares withheld for taxes | — | — | ( i 47,599) | — | — | ( i 239) | — | — | — | ( i 239) | ||||||||||||||||||||||
Issuance of common stock under employee stock purchase plan | — | — | i 84,369 | — | — | i 197 | — | — | — | i 197 | ||||||||||||||||||||||
Convertible preferred dividend | — | — | — | — | — | ( i 4,400) | — | — | — | ( i 4,400) | ||||||||||||||||||||||
Comprehensive loss | — | — | — | — | — | — | ( i 42,089) | ( i 10,104) | ( i 857) | ( i 53,050) | ||||||||||||||||||||||
Balances, September 30, 2020 | i 1 | $ | i — | i 53,054,960 | $ | i 5 | $ | ( i 3,885) | $ | i 559,037 | $ | ( i 241,710) | $ | ( i 41,164) | $ | i 6,728 | $ | i 279,011 |
Preferred Stock | Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Non-Controlling Interest | Total Stockholders’ Equity | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Amount | ||||||||||||||||||||||||||||
Balances, June 30, 2020 | i 1 | $ | i — | i 52,875,089 | i 5 | ( i 3,885) | $ | i 562,584 | $ | ( i 219,823) | $ | ( i 40,831) | $ | i 7,222 | $ | i 305,272 | ||||||||||||||||
Stock-based compensation | — | — | — | — | — | i 872 | — | — | — | i 872 | ||||||||||||||||||||||
Issuance of stock, net of forfeitures | — | — | i 187,302 | — | — | — | — | — | — | — | ||||||||||||||||||||||
Shares withheld for taxes | — | — | ( i 7,431) | — | — | ( i 19) | — | — | — | ( i 19) | ||||||||||||||||||||||
Issuance of common stock under employee stock purchase plan | — | — | i — | — | — | i — | — | — | — | i — | ||||||||||||||||||||||
Convertible preferred dividend | — | — | — | — | — | ( i 4,400) | — | — | — | ( i 4,400) | ||||||||||||||||||||||
Comprehensive (loss) income | — | — | — | — | — | — | ( i 21,887) | ( i 333) | ( i 494) | ( i 22,714) | ||||||||||||||||||||||
Balances, September 30, 2020 | i 1 | $ | i — | i 53,054,960 | i 5 | ( i 3,885) | $ | i 559,037 | $ | ( i 241,710) | $ | ( i 41,164) | $ | i 6,728 | $ | i 279,011 |
Preferred Stock | Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Non-Controlling Interest | Total Stockholders’ Equity | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Amount | ||||||||||||||||||||||||||||
Balances, December 31, 2018 | i 1 | $ | i — | i 51,071,573 | $ | i 5 | $ | ( i 3,885) | $ | i 535,819 | $ | ( i 138,789) | $ | ( i 28,837) | $ | i 8,263 | $ | i 372,576 | ||||||||||||||
Stock-based compensation | — | — | — | — | — | i 2,256 | — | — | — | i 2,256 | ||||||||||||||||||||||
Issuance of stock, net of forfeitures | — | — | i 521,386 | — | — | — | — | — | — | — | ||||||||||||||||||||||
Comprehensive loss | — | — | — | — | — | — | ( i 31,599) | ( i 1,654) | ( i 336) | ( i 33,589) | ||||||||||||||||||||||
Balances, September 30, 2019 | i 1 | $ | i — | i 51,592,959 | $ | i 5 | $ | ( i 3,885) | $ | i 538,075 | $ | ( i 170,388) | $ | ( i 30,491) | $ | i 7,927 | $ | i 341,243 |
Preferred Stock | Common Stock | Treasury Stock | Additional Paid-in Capital | Accumulated Deficit | Accumulated Other Comprehensive Loss | Non-Controlling Interest | Total Stockholders’ Equity | |||||||||||||||||||||||||
Shares | Amount | Shares | Amount | Amount | ||||||||||||||||||||||||||||
Balances, June 30, 2019 | i 1 | $ | i — | i 51,620,770 | $ | i 5 | $ | ( i 3,885) | $ | i 537,259 | $ | ( i 173,677) | $ | ( i 26,473) | $ | i 8,205 | $ | i 341,434 | ||||||||||||||
Stock-based compensation | — | — | — | — | — | i 816 | — | — | — | i 816 | ||||||||||||||||||||||
Forfeiture of stock, net of issuances | — | — | ( i 27,811) | — | — | — | — | — | — | — | ||||||||||||||||||||||
Comprehensive income (loss) | — | — | — | — | — | — | i 3,289 | ( i 4,018) | ( i 278) | ( i 1,007) | ||||||||||||||||||||||
Balances, September 30, 2019 | i 1 | $ | i — | i 51,592,959 | $ | i 5 | $ | ( i 3,885) | $ | i 538,075 | $ | ( i 170,388) | $ | ( i 30,491) | $ | i 7,927 | $ | i 341,243 |
(in thousands) | Nine Months Ended September 30, 2020 | Nine Months Ended September 30, 2019 | ||||||
Cash flows from operating activities: | ||||||||
Net loss | $ | ( i 42,946) | $ | ( i 31,935) | ||||
Adjustments to reconcile net loss to net cash used in operating activities: | ||||||||
Depreciation and amortization | i 34,775 | i 36,692 | ||||||
(Benefit) provision for bad debts | ( i 124) | i 215 | ||||||
Stock-based compensation | i 2,473 | i 2,256 | ||||||
Impairment of intangible assets | i — | i 992 | ||||||
Amortization of deferred financing costs | i 2,342 | i 2,032 | ||||||
Interest income on interest rate swap | ( i 1,809) | ( i 1,070) | ||||||
Accretion of contingent consideration | i — | i 2,669 | ||||||
Change in fair value of contingent consideration | i — | i 128 | ||||||
Deferred income taxes | i 18,086 | ( i 14,499) | ||||||
Loss on sales of property and equipment | i 155 | i 2 | ||||||
Changes in operating assets and liabilities: | ||||||||
Accounts receivable | ( i 4,297) | ( i 1,499) | ||||||
Inventories | ( i 2,281) | ( i 4,424) | ||||||
Prepaid expenses and other current assets | ( i 6,784) | ( i 1,429) | ||||||
Accounts payable | ( i 1,274) | i 3,855 | ||||||
Accrued expenses and other liabilities | i 2,344 | ( i 2,958) | ||||||
Income taxes payable | i 2,846 | ( i 95) | ||||||
Other assets and liabilities | ( i 3,865) | i 384 | ||||||
Net cash used in operating activities | ( i 359) | ( i 8,684) | ||||||
Cash flows from investing activities: | ||||||||
Cash paid for property and equipment | ( i 2,131) | ( i 3,271) | ||||||
Other investments | i — | ( i 250) | ||||||
Net cash used in investing activities | ( i 2,131) | ( i 3,521) | ||||||
Cash flows from financing activities: | ||||||||
Net proceeds from issuance of convertible preferred stock | i 145,490 | i — | ||||||
Costs associated with issuance of convertible preferred stock | ( i 7,006) | i — | ||||||
Payment of preferred dividends | ( i 2,200) | i — | ||||||
Proceeds from long-term debt | i 2,042 | i — | ||||||
Repayment of long-term debt | ( i 131,599) | ( i 5,056) | ||||||
Payment of deferred financing costs | ( i 7,988) | i — | ||||||
Proceeds from issuance of stock under employee stock purchase plan | i 259 | i — | ||||||
Net cash used in financing activities | ( i 1,002) | ( i 5,056) | ||||||
Effect of exchange rate changes on cash and cash equivalents and restricted cash | ( i 1,176) | i 1,682 | ||||||
Net decrease in cash and cash equivalents and restricted cash | ( i 4,668) | ( i 15,579) | ||||||
Cash and cash equivalents and restricted cash, beginning of period | i 29,817 | i 34,852 | ||||||
Cash and cash equivalents, end of period | $ | i 25,149 | $ | i 19,273 | ||||
Supplemental disclosures of cash flow information: | ||||||||
Cash paid for: | ||||||||
Cash paid for interest | $ | i 18,381 | $ | i 18,007 | ||||
Cash paid for income taxes | $ | i 1,733 | $ | i 2,469 | ||||
Supplemental schedule of non-cash investing and financing activities: | ||||||||
Accrued purchases of property and equipment | $ | i 146 | $ | i 62 |
(in thousands) | |||||||||||||||||
Region | North America (1) | EMEA (2) | Latin America (3) | Asia Pacific (4) | Total Revenues | ||||||||||||
Product | |||||||||||||||||
1-MCP based | $ | i 17,122 | $ | i 28,906 | $ | i 845 | $ | i 1,165 | $ | i 48,038 | |||||||
Fungicides, waxes, coatings and disinfectants | i 534 | i 3,011 | i 575 | i — | i 4,120 | ||||||||||||
Other* | i 190 | i 115 | i 210 | i 97 | i 612 | ||||||||||||
$ | i 17,846 | $ | i 32,032 | $ | i 1,630 | $ | i 1,262 | $ | i 52,770 | ||||||||
Pattern of Revenue Recognition | |||||||||||||||||
Products transferred at a point in time | $ | i 17,663 | $ | i 31,921 | $ | i 1,420 | $ | i 1,165 | $ | i 52,169 | |||||||
Services transferred over time | i 183 | i 111 | i 210 | i 97 | i 601 | ||||||||||||
$ | i 17,846 | $ | i 32,032 | $ | i 1,630 | $ | i 1,262 | $ | i 52,770 |
(in thousands) | |||||||||||||||||
Region | North America (1) | EMEA (2) | Latin America (3) | Asia Pacific (4) | Total Revenues | ||||||||||||
Product | |||||||||||||||||
1-MCP based | $ | i 19,726 | $ | i 22,377 | $ | i 1,680 | $ | i 1,605 | $ | i 45,388 | |||||||
Fungicides, waxes, coatings and disinfectants | i — | i 2,857 | i 198 | i — | i 3,055 | ||||||||||||
Other* | i 218 | i 86 | i 108 | i 117 | i 529 | ||||||||||||
$ | i 19,944 | $ | i 25,320 | $ | i 1,986 | $ | i 1,722 | $ | i 48,972 | ||||||||
Pattern of Revenue Recognition | |||||||||||||||||
Products transferred at a point in time | $ | i 19,802 | $ | i 25,238 | $ | i 1,877 | $ | i 1,605 | $ | i 48,522 | |||||||
Services transferred over time | i 142 | i 82 | i 109 | i 117 | i 450 | ||||||||||||
$ | i 19,944 | $ | i 25,320 | $ | i 1,986 | $ | i 1,722 | $ | i 48,972 |
(in thousands) | |||||||||||||||||
Region | North
America (1) | EMEA (2) | Latin America (3) | Asia Pacific (4) | Total Revenues | ||||||||||||
Product | |||||||||||||||||
1-MCP based | $ | i 19,264 | $ | i 37,223 | $ | i 23,217 | $ | i 11,538 | $ | i 91,242 | |||||||
Fungicides, waxes, coatings and disinfectants | i 534 | i 9,650 | i 1,750 | i — | i 11,934 | ||||||||||||
Other* | i 722 | i 700 | i 938 | i 239 | i 2,599 | ||||||||||||
$ | i 20,520 | $ | i 47,573 | $ | i 25,905 | $ | i 11,777 | $ | i 105,775 | ||||||||
Pattern of Revenue Recognition | |||||||||||||||||
Products transferred at a point in time | $ | i 19,823 | $ | i 46,887 | $ | i 25,338 | $ | i 11,538 | $ | i 103,586 | |||||||
Services transferred over time | i 697 | i 686 | i 567 | i 239 | i 2,189 | ||||||||||||
$ | i 20,520 | $ | i 47,573 | $ | i 25,905 | $ | i 11,777 | $ | i 105,775 |
(in thousands) | |||||||||||||||||
Region | North America (1) | EMEA (2) | Latin America (3) | Asia Pacific (4) | Total Revenues | ||||||||||||
Product | |||||||||||||||||
1-MCP based | $ | i 23,084 | $ | i 31,965 | $ | i 27,503 | $ | i 11,287 | $ | i 93,839 | |||||||
Fungicides, waxes, coatings and disinfectants | i — | i 11,365 | i 1,458 | i — | i 12,823 | ||||||||||||
Other* | i 954 | i 927 | i 381 | i 171 | i 2,433 | ||||||||||||
$ | i 24,038 | $ | i 44,257 | $ | i 29,342 | $ | i 11,458 | $ | i 109,095 | ||||||||
Pattern of Revenue Recognition | |||||||||||||||||
Products transferred at a point in time | $ | i 23,380 | $ | i 43,374 | $ | i 29,159 | $ | i 11,309 | $ | i 107,222 | |||||||
Services transferred over time | i 658 | i 883 | i 183 | i 149 | i 1,873 | ||||||||||||
$ | i 24,038 | $ | i 44,257 | $ | i 29,342 | $ | i 11,458 | $ | i 109,095 |
(in thousands) | Balance at January 1, 2020 | Additions | Deductions | Balance at September 30, 2020 | ||||||||||
Contract assets: | ||||||||||||||
Unbilled revenue | $ | i 1,666 | i 11,670 | ( i 9,423) | $ | i 3,913 | ||||||||
Contract liabilities: | ||||||||||||||
Deferred revenue | $ | i 1,175 | i 4,437 | ( i 4,239) | $ | i 1,373 |
(in thousands) | Balance at January 1, 2019 | Additions | Deductions | Balance at December 31, 2019 | ||||||||||
Contract assets: | ||||||||||||||
Unbilled revenue | $ | i 1,956 | i 10,029 | ( i 10,319) | $ | i 1,666 | ||||||||
Contract liabilities: | ||||||||||||||
Deferred revenue | $ | i 1,280 | i 3,032 | ( i 3,137) | $ | i 1,175 |
(in thousands) | September 30, 2020 | December 31, 2019 | ||||||
Raw material | $ | i 3,026 | $ | i 3,401 | ||||
Work-in-process | i 8,575 | i 7,278 | ||||||
Finished goods | i 11,619 | i 10,974 | ||||||
Supplies | i 1,224 | i 968 | ||||||
Total inventories | $ | i 24,444 | $ | i 22,621 |
(in thousands) | September 30, 2020 | December 31, 2019 | ||||||
VAT receivable | $ | i 7,627 | $ | i 4,925 | ||||
Prepaid income tax asset | i 5,349 | i 3,616 | ||||||
Prepaid and other current assets | i 4,289 | i 3,261 | ||||||
Total other current assets | $ | i 17,265 | $ | i 11,802 |
(in thousands, except for useful life data) | Useful
life (years) | September 30, 2020 | December 31, 2019 | ||||||||
Buildings and leasehold improvements | i 7- i 20 | $ | i 7,032 | $ | i 6,508 | ||||||
Machinery & equipment | i 1- i 12 | i 11,953 | i 10,954 | ||||||||
Furniture | i 1- i 12 | i 2,944 | i 2,681 | ||||||||
Construction in progress | i 1,149 | i 902 | |||||||||
i 23,078 | i 21,045 | ||||||||||
Less: accumulated depreciation | ( i 9,803) | ( i 7,868) | |||||||||
Total property and equipment, net | $ | i 13,275 | $ | i 13,177 |
(in thousands) | September 30, 2020 | December 31, 2019 | ||||||
Beginning balance | $ | i 6,323 | $ | i 6,670 | ||||
Foreign
currency translation | i 282 | ( i 347) | ||||||
Ending balance | $ | i 6,605 | $ | i 6,323 |
September 30, 2020 | December 31, 2019 | |||||||||||||||||||||||||
(in thousands) | Gross Carrying Amount | Accumulated Amortization | Impairment | Net | Gross Carrying Amount | Accumulated Amortization | Impairment | Net | ||||||||||||||||||
Other intangible assets: | ||||||||||||||||||||||||||
Developed technology | $ | i 798,240 | $ | ( i 244,918) | $ | — | $ | i 553,322 | $ | i 758,760 | $ | ( i 206,998) | $ | — | $ | i 551,762 | ||||||||||
In-process research and development | i — | i — | — | i — | i 39,000 | ( i 7,222) | — | i 31,778 | ||||||||||||||||||
Trade name | i 27,158 | — | — | i 27,158 | i 27,200 | — | i 27,200 | |||||||||||||||||||
Service provider network | i 2,000 | — | — | i 2,000 | i 2,000 | — | — | i 2,000 | ||||||||||||||||||
Customer relationships | i 18,551 | ( i 3,548) | — | i 15,003 | i 18,058 | ( i 2,993) | — | i 15,065 | ||||||||||||||||||
Software | i 10,691 | ( i 8,967) | i — | i 1,724 | i 9,861 | ( i 5,347) | ( i 992) | i 3,522 | ||||||||||||||||||
Other | i 100 | ( i 71) | — | i 29 | i 100 | ( i 58) | — | i 42 | ||||||||||||||||||
Total intangible assets | $ | i 856,740 | $ | ( i 257,504) | $ | i — | $ | i 599,236 | $ | i 854,979 | $ | ( i 222,618) | $ | ( i 992) | $ | i 631,369 |
(in thousands) | Amount | ||||
2020 (remaining) | $ | i 12,045 | |||
2021 | i 41,730 | ||||
2022 | i 40,893 | ||||
2023 | i 40,791 | ||||
2024 | i 40,791 | ||||
Thereafter | i 393,828 | ||||
Total | $ | i 570,078 |
(in thousands) | September 30, 2020 | December 31, 2019 | ||||||
Right-of-use asset | $ | i 5,657 | $ | i 6,599 | ||||
Long term sales-type lease receivable | i 2,354 | i 2,501 | ||||||
Other long term receivable | i 3,438 | i 3,061 | ||||||
Total other assets | $ | i 11,449 | $ | i 12,161 |
(in thousands) | September 30, 2020 | December 31, 2019 | ||||||
Accrued compensation and benefits | $ | i 7,111 | $ | i 7,307 | ||||
Accrued taxes | i 6,501 | i 3,017 | ||||||
Lease liability | i 1,368 | i 1,493 | ||||||
Accrued rebates payable | i 3,001 | i 1,377 | ||||||
Insurance premium financing payable | i 1,151 | i 1,000 | ||||||
Severance | i 218 | i 444 | ||||||
Deferred revenue | i 1,373 | i 1,175 | ||||||
Accrued interest | i 66 | i 71 | ||||||
Interest rate swap | i 290 | i — | ||||||
Other | i 5,586 | i 8,466 | ||||||
Total accrued and other current liabilities | $ | i 26,665 | $ | i 24,350 |
(in thousands) | September 30, 2020 | December 31, 2019 | ||||||
Total term loan outstanding | $ | i 275,000 | $ | i 405,875 | ||||
Unamortized deferred issuance costs | ( i 9,018) | ( i 3,886) | ||||||
Tecnidex loan outstanding | i 2,184 | i 750 | ||||||
Less: Amounts due within one year | i 3,316 | i 4,675 | ||||||
Total long-term debt due after one year | $ | i 264,850 | $ | i 398,064 |
(in thousands) | Amount | ||||
2020 (remaining) | $ | i 815 | |||
2021 | i 3,348 | ||||
2022 | i 3,390 | ||||
2023 | i 3,181 | ||||
2024 and thereafter | $ | i 266,450 | |||
Total | $ | i 277,184 |
(in thousands) | Three months ended September 30, 2020 | Three months ended September 30, 2019 | Nine months ended September 30, 2020 | Nine months ended September 30, 2019 | ||||||||||
Operating leases | $ | i 662 | $ | i 591 | $ | i 1,916 | $ | i 1,849 | ||||||
Short-term
leases (1) | i 6 | i 5 | i 182 | i 52 | ||||||||||
Total lease expense | $ | i 668 | $ | i 596 | $ | i 2,098 | $ | i 1,901 |
Other information on operating leases | Nine months ended September 30, 2020 | Nine months ended September 30, 2019 | ||||||
Cash payments included in operating cash flows | $ | i 1,645 | $ | i 1,625 | ||||
Right-of-use assets obtained in exchange for new lease | $ | i 769 | $ | i 376 | ||||
Weighted average discount rate | i 9.11 | % | i 9.33 | % | ||||
Weighted average remaining lease term in years | i 5.09 | i 5.53 |
(in thousands) | Lease Liability | ||||
Remainder of 2020 | $ | i 485 | |||
2021 | i 1,784 | ||||
2022 | i 1,496 | ||||
2023 | i 1,228 | ||||
2024 and thereafter | i 2,290 | ||||
Total undiscounted lease payments | i 7,283 | ||||
Less: present value adjustment | i 1,450 | ||||
Operating lease liability | $ | i 5,833 |
(in thousands) | Future lease Payments | ||||
2020 | $ | i 1,939 | |||
2021 | i 1,670 | ||||
2022 | i 1,509 | ||||
2023 | i 1,294 | ||||
2024 and thereafter | i 2,380 | ||||
Total undiscounted lease payments | i 8,792 | ||||
Less: present value adjustment | i 1,960 | ||||
Operating lease liability | $ | i 6,832 |
(in thousands) | September 30, 2020 | December 31, 2019 | ||||||
Lease liability | $ | i 4,465 | $ | i 5,339 | ||||
Other
(1) | i 1,524 | i 1,907 | ||||||
Total other noncurrent liabilities | $ | i 5,989 | $ | i 7,246 |
Series B-1 Convertible Preferred Stock | Series B-2 Convertible Preferred Stock | Series B Convertible Preferred Stock | ||||||||||||||||||
(in thousands, except share) | Shares | Amount | Shares | Amount | Shares | Amount | ||||||||||||||
Balance at December 31, 2019 | i — | $ | i — | i — | $ | i — | i — | $ | i — | |||||||||||
Issuance of preferred stock | i 150,000 | i 150,000 | i 150,000 | i — | i 150,000 | i 150,000 | ||||||||||||||
Exchange to Series B preferred stock | ( i 150,000) | ( i 150,000) | ( i 150,000) | i — | i — | i — | ||||||||||||||
Issuance-related expenses | — | i — | — | i — | — | ( i 11,516) | ||||||||||||||
Additional preferred shares | i — | i — | i — | i — | i — | i 2,200 | ||||||||||||||
Balance at September 30, 2020 | i — | $ | i — | i — | $ | i — | i 150,000 | $ | i 140,684 |
Three Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine
Months Ended September 30, 2019 | |||||||||||
Basic weighted-average common shares outstanding | i 51,001,852 | i 50,227,590 | i 50,765,829 | i 50,138,835 | ||||||||||
Effect of dilutive options, performance stock units and restricted stock | i — | i 60,714 | i — | i — | ||||||||||
Diluted weighted-average shares outstanding | i 51,001,852 | i 50,288,304 | i 50,765,829 | i 50,138,835 |
Three Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine
Months Ended September 30, 2019 | |||||||||||
Convertible preferred stock | 21,526,522 | — | 7,227,883 | — | ||||||||||
Stock-based compensation awards(1): | ||||||||||||||
Stock options | i 799,570 | i 1,028,583 | i 804,267 | i 949,987 | ||||||||||
Restricted stock to non-directors | i 1,811,016 | i 749,510 | i 1,079,151 | i 624,930 | ||||||||||
Warrants: | ||||||||||||||
Private placement warrants | i 2,075,652 | i 6,160,000 | i 4,788,613 | i 6,160,000 | ||||||||||
Public warrants | i 3,309,948 | i 9,823,072 | i 7,636,184 | i 9,823,072 |
(in thousands) | Three Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine Months Ended September 30, 2019 | ||||||||||
AgroFresh Core | ||||||||||||||
Revenues | $ | i 49,343 | $ | i 45,917 | $ | i 94,723 | $ | i 96,272 | ||||||
Gross Profit | i 38,283 | i 34,182 | i 73,080 | i 72,679 | ||||||||||
Tecnidex | ||||||||||||||
Revenues | i 3,427 | i 3,055 | i 11,052 | i 12,823 | ||||||||||
Gross Profit | i 976 | i 898 | i 4,203 | i 4,900 | ||||||||||
Total Revenues | $ | i 52,770 | $ | i 48,972 | $ | i 105,775 | $ | i 109,095 | ||||||
Total Gross Profit | $ | i 39,259 | $ | i 35,080 | $ | i 77,283 | $ | i 77,579 |
(in thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||
Liability-classified
stock compensation (1) | $ | i — | $ | i — | $ | i 294 | $ | i 294 | ||||||
Interest rate swap | i — | i — | i 290 | i 290 | ||||||||||
Total | $ | i — | $ | i — | $ | i 584 | $ | i 584 |
(in thousands) | Level 1 | Level 2 | Level 3 | Total | ||||||||||
Liability-classified
stock compensation (1) | $ | i — | $ | i — | $ | i 218 | $ | i 218 | ||||||
Interest rate swap | i — | i — | ( i 95) | ( i 95) | ||||||||||
Total | $ | i — | $ | i — | $ | i 123 | $ | i 123 |
September 30, 2020 | |||||||||||
Grant date fair value | $ | i 1.70 | — | $ i 7.28 | |||||||
Risk-free interest rate | i 0.27 | % | — | i 2.39% | |||||||
Expected life (years) | i 2.71 | — | i 2.75 | ||||||||
Estimated volatility factor | i 65.1 | % | — | i 69.9% | |||||||
Expected dividends | i None |
(in thousands) | Liability-classified stock compensation | Interest rate swap | Total | ||||||||
Balance, December 31, 2019 | $ | i 218 | $ | ( i 95) | $ | i 123 | |||||
Stock compensation activity | i 76 | i — | i 76 | ||||||||
Mark-to-market adjustment | i — | i 385 | i 385 | ||||||||
Balance, September 30, 2020 | $ | i 294 | $ | i 290 | $ | i 584 |
(in thousands) | Three Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine Months Ended September 30, 2019 | ||||||||||
Net sales | $ | 52,770 | $ | 48,972 | $ | 105,775 | $ | 109,095 | ||||||
Cost of sales (excluding amortization, shown separately below) | 13,511 | 13,892 | 28,492 | 31,516 | ||||||||||
Gross profit | 39,259 | 35,080 | 77,283 | 77,579 | ||||||||||
Research and development expenses | 2,852 | 2,566 | 8,389 | 9,720 | ||||||||||
Selling, general and administrative expenses | 13,494 | 14,998 | 39,925 | 47,044 | ||||||||||
Amortization of intangibles | 10,973 | 11,754 | 32,866 | 35,136 | ||||||||||
Impairment of long lived assets | — | — | — | 992 | ||||||||||
Change in fair value of contingent consideration | — | (229) | — | 128 | ||||||||||
Grant income | — | — | (2,974) | — | ||||||||||
Operating income (loss) | 11,940 | 5,991 | (923) | (15,441) | ||||||||||
Other income (expense) | 96 | (81) | 1,596 | (119) | ||||||||||
Debt modification and extinguishment expenses | (5,028) | — | (5,028) | — | ||||||||||
Gain (loss) on foreign currency exchange | 1,390 | 54 | 2,466 | (2,884) | ||||||||||
Interest expense, net | (4,922) | (8,606) | (18,401) | (26,021) | ||||||||||
Gain (loss) before income taxes | 3,476 | (2,642) | (20,290) | (44,465) | ||||||||||
Income taxes expense (benefit) | 25,857 | (5,653) | 22,656 | (12,530) | ||||||||||
Net (loss) income including non-controlling interests | (22,381) | 3,011 | (42,946) | (31,935) | ||||||||||
Less: Net loss attributable to non-controlling interests | (494) | (278) | (857) | (336) | ||||||||||
Net (loss) income attributable to AgroFresh Solutions, Inc | (21,887) | 3,289 | (42,089) | (31,599) | ||||||||||
Less: Dividends on convertible preferred stock | 4,400 | — | 4,400 | — | ||||||||||
(Loss) income attributable to AgroFresh Solutions, Inc. common stockholders | $ | (26,287) | $ | 3,289 | $ | (46,489) | $ | (31,599) |
(in thousands) | Three
Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine Months Ended September 30, 2019 | ||||||||||
GAAP net (loss) income including non-controlling interests | $ | (22,381) | $ | 3,011 | $ | (42,946) | $ | (31,935) | ||||||
Expense (benefit) for income taxes | 25,857 | (5,653) | 22,656 | (12,530) | ||||||||||
Interest expense (1) | 4,922 | 8,606 | 18,401 | 26,021 | ||||||||||
Depreciation and amortization | 11,630 | 12,356 | 34,775 | 36,692 | ||||||||||
Non-GAAP EBITDA | $ | 20,028 | $ | 18,320 | $ | 32,886 | $ | 18,248 | ||||||
Share-based compensation | 943 | 959 | 2,705 | 2,111 | ||||||||||
Severance related costs (2) | 356 | 344 | 430 | 1,040 | ||||||||||
Other
non-recurring costs (3) | — | 1,297 | 2,383 | 6,305 | ||||||||||
(Gain) loss on foreign currency exchange (4) | (1,390) | (54) | (2,466) | 2,884 | ||||||||||
Debt modification and extinguishment costs | 5,028 | — | 5,028 | — | ||||||||||
Mark-to-market
adjustments, net (5) | — | (229) | — | 128 | ||||||||||
Impairment of intangible assets (6) | — | — | — | 992 | ||||||||||
Grant income | — | — | (2,974) | — | ||||||||||
Litigation recovery | — | — | (1,600) | — | ||||||||||
Non-GAAP Adjusted EBITDA | $ | 24,965 | $ | 20,637 | $ | 36,392 | $ | 31,708 |
(in thousands) | Three Months Ended September 30, 2020 | Three Months Ended September 30, 2019 | Nine Months Ended September 30, 2020 | Nine
Months Ended September 30, 2019 | ||||||||||
GAAP net sales | $ | 52,770 | $ | 48,972 | $ | 105,775 | $ | 109,095 | ||||||
Impact from changes in foreign currency exchange rates | (1,064) | — | 2,738 | — | ||||||||||
Non-GAAP
constant currency net sales (1) | $ | 51,706 | $ | 48,972 | $ | 108,513 | $ | 109,095 |
(in thousands) | Nine Months Ended September 30, 2020 | Nine Months Ended September 30, 2019 | ||||||
Net cash used in operating activities | $ | (359) | $ | (8,684) | ||||
Net cash used in investing activities | $ | (2,131) | $ | (3,521) | ||||
Net cash used in financing activities | $ | (1,002) | $ | (5,056) |
Exhibit No. | Description | |||||||||||||
(1) | Second Amended and Restated Certificate of Incorporation, filed with the Secretary of State of the State of Delaware on July 31, 2015. | |||||||||||||
(4) | Certificate of Amendment to the Second Amended and Restated Certificate of Incorporation. | |||||||||||||
(1) | Series A Certificate of Designation. | |||||||||||||
(6) | Certificate of Designation of Series B Convertible Preferred Stock. | |||||||||||||
(2) | Amended and Restated Bylaws. | |||||||||||||
3.6 | (3) | Amendment to the Amended and Restated Bylaws of AgroFresh Solutions, Inc., effective as of September 3, 2015. | ||||||||||||
3.7 | (5) | Amendment to the Amended and Restated Bylaws of AgroFresh Solutions, Inc., effective as of November 2, 2017. | ||||||||||||
(1) | Specimen Common Stock Certificate. | |||||||||||||
(1) | Specimen Warrant Certificate. | |||||||||||||
(7) | Amended and Restated Credit Agreement, dated July 27, 2020. | |||||||||||||
(7) | Registration Rights Agreement, dated July 27, 2020, between the Company and PSP AGFS Holdings, L.P. | |||||||||||||
* | Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Exchange Act of 1934, as amended. | |||||||||||||
* | Certification of Chief Financial Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a), promulgated under the Securities Act of 1934, as amended. | |||||||||||||
* | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | |||||||||||||
101.INS | * | XBRL Instance Document | ||||||||||||
101.SCH | * | XBRL Taxonomy Extension Schema Document | ||||||||||||
101.CAL | * | XBRL Taxonomy Extension Calculation Linkbase Document | ||||||||||||
101.DEF | * | XBRL Taxonomy Extension Definition Linkbase Document | ||||||||||||
101.LAB | * | XBRL Taxonomy Extension Label Linkbase Document | ||||||||||||
101.PRE | * | XBRL Taxonomy Extension Presentation Linkbase Document |
AgroFresh Solutions, Inc. | ||||||||
Date: | November 5, 2020 | |||||||
/s/ Jordi Ferre | ||||||||
By: | Jordi Ferre | |||||||
Title: | Chief Executive Officer | |||||||
/s/ Graham Miao | ||||||||
By: | Graham Miao | |||||||
Title: | Chief Financial Officer |
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
12/31/24 | ||||
6/30/24 | ||||
12/31/22 | ||||
1/27/22 | ||||
7/31/21 | ||||
7/27/21 | ||||
12/31/20 | 10-K, 4 | |||
12/15/20 | ||||
Filed on: | 11/5/20 | 8-K | ||
10/22/20 | ||||
For Period end: | 9/30/20 | |||
9/28/20 | 8-K | |||
9/25/20 | 4 | |||
9/22/20 | 4, 8-K | |||
8/7/20 | 8-K | |||
7/31/20 | 4 | |||
7/29/20 | 3, 8-K | |||
7/27/20 | 3, 8-K | |||
6/30/20 | 10-Q, 4 | |||
6/25/20 | 424B5, 8-K | |||
6/13/20 | 8-K | |||
3/27/20 | ||||
3/23/20 | ||||
3/12/20 | 8-K | |||
1/1/20 | ||||
12/31/19 | 10-K, 10-K/A, 4 | |||
12/15/19 | ||||
10/14/19 | 8-K | |||
9/30/19 | 10-Q, 4 | |||
7/1/19 | 4 | |||
6/30/19 | 10-Q | |||
1/1/19 | ||||
12/31/18 | 10-K, 4, 8-K | |||
7/1/18 | ||||
6/30/18 | 10-Q, NT 10-Q | |||
12/31/17 | 10-K, 5, NT 10-K | |||
12/1/17 | 4 | |||
11/9/17 | 10-Q | |||
11/7/17 | ||||
11/2/17 | ||||
6/7/17 | 8-K | |||
4/4/17 | 4 | |||
9/10/15 | 8-K | |||
9/3/15 | 8-K | |||
8/6/15 | 8-K, 8-K/A | |||
7/31/15 | 25-NSE, 3, 8-K, 8-K/A | |||
7/16/15 | 8-K, DEF 14A, UPLOAD | |||
4/30/15 | 8-K | |||
List all Filings |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 9/28/20 AgroFresh Solutions, Inc. 8-K:3,5,9 9/22/20 14:558K 7/29/20 AgroFresh Solutions, Inc. 8-K:1,3,5,7 7/27/20 15:2.6M Toppan Merrill/FA 11/09/17 AgroFresh Solutions, Inc. 10-Q 9/30/17 74:5M 6/07/17 AgroFresh Solutions, Inc. 8-K:5,9 6/06/17 3:93K 9/10/15 AgroFresh Solutions, Inc. 8-K:5,8,9 9/03/15 3:46K Toppan Merrill/FA 8/06/15 AgroFresh Solutions, Inc. 8-K:1,2,3,5 7/31/15 13:3.6M Toppan Merrill/FA 7/16/15 AgroFresh Solutions, Inc. DEF 14A 7/29/15 1:5M Toppan Merrill-FA |